Here are the latest quarterly results of the stocks in the . For more detailed updates, check the latest stock quotes.
Click on title to sort | Dec 2021 | Dec 2022 | YoY %-Change | Get More Info | ||||
---|---|---|---|---|---|---|---|---|
Name | Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (%) |
PAT (%) |
P/E* (x) |
|
AUROBINDO PHARMA | 60,022 | 6,114 | 64,071 | 4,916 | 6.7% | -19.6% | 15.3 | More Info
|
AUROBINDO PHARMA | 60,022 | 6,114 | 64,071 | 4,916 | 6.7% | -19.6% | 15.3 | More Info
|
AUROBINDO PHARMA | 60,022 | 6,114 | 64,071 | 4,916 | 6.7% | -19.6% | 15.3 | More Info
|
AUROBINDO PHARMA | 60,022 | 6,114 | 64,071 | 4,916 | 6.7% | -19.6% | 15.3 | More Info
|
BIOCON | 21,742 | 2,668 | 29,411 | 349 | 35.3% | -86.9% | 29.4 | More Info
|
BIOCON | 21,742 | 2,668 | 29,411 | 349 | 35.3% | -86.9% | 29.4 | More Info
|
CIPLA | 54,789 | 7,590 | 58,101 | 8,081 | 6.0% | 6.5% | 15.2 | More Info
|
CIPLA | 54,789 | 7,590 | 58,101 | 8,081 | 6.0% | 6.5% | 15.2 | More Info
|
CIPLA | 54,789 | 7,590 | 58,101 | 8,081 | 6.0% | 6.5% | 15.2 | More Info
|
DIVIS LABORATORIES | 24,932 | 9,022 | 17,080 | 3,060 | -31.5% | -66.1% | 53.8 | More Info
|
DIVIS LABORATORIES | 24,932 | 9,022 | 17,080 | 3,060 | -31.5% | -66.1% | 53.8 | More Info
|
GLENMARK PHARMA | 31,734 | 2,398 | 31,002 | 1,858 | -2.3% | -22.5% | N.A. | More Info
|
LUPIN | 41,609 | 5,491 | 43,222 | 1,577 | 3.9% | -71.3% | 18.4 | More Info
|
LUPIN | 41,609 | 5,491 | 43,222 | 1,577 | 3.9% | -71.3% | 18.4 | More Info
|
LUPIN | 41,609 | 5,491 | 43,222 | 1,577 | 3.9% | -71.3% | 18.4 | More Info
|
PIRAMAL ENTERPRISES | 22,852 | 5,815 | 28,112 | 34,913 | 23.0% | 500.4% | N.A. | More Info
|
SUN PHARMA | 98,631 | 21,308 | 112,410 | 21,880 | 14.0% | 2.7% | 13.0 | More Info
|
SUN PHARMA | 98,631 | 21,308 | 112,410 | 21,880 | 14.0% | 2.7% | 13.0 | More Info
|
ZYDUS LIFESCIENCES | 36,398 | 4,948 | 42,571 | 5,849 | 17.0% | 18.2% | 11.4 | More Info
|
ZYDUS LIFESCIENCES | 36,398 | 4,948 | 42,571 | 5,849 | 17.0% | 18.2% | 11.4 | More Info
|
Sector Aggregate | 947,275 | 147,800 | 1,022,312 | 147,682 | 7.9% | -0.1% | ||
* Trailing 12 months earnings, excluding extraordinary / exceptional items. |